Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

J&J Announces Project to Prevent Type 1 Diabetes

June 11, 2015 9:57 am | by Seth Augenstein, Digital Reporter | News | Comments

Johnson and Johnson has announced a partnership with a renowned immunologist to find a way to stop the root cause of Type 1 diabetes before it fully develops in young patients. Read more..


Amgen to Discuss Repatha (Evolocumab) for Treatment Of High Cholesterol

June 11, 2015 9:42 am | News | Comments

Amgen today announced that the Company will discuss the data supporting the RepathaTM (evolocumab) Biologics License Application (BLA) for the treatment of high cholesterol with the U.S. Food and Drug Administration's (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC). Read more...


EULAR 2015: Pfizer to Present New Data on Xeljanz

June 11, 2015 9:04 am | News | Comments

Highlights include over six-years of safety and efficacy data from two long-term extension studies. Read more...


EULAR 2015: Roche Gains Breakthrough Designation for Systemic Sclerosis Drug

June 11, 2015 8:55 am | News | Comments

Roche also initiated a global Phase 3 study in SSc. Read more...


New System to Detect Patient's Antibiotic Resistance to Take Just 30 Minutes

June 11, 2015 8:44 am | by St. George's University | News | Comments

A new device being developed by medical experts will transform the time it takes to detect antibiotic resistance in patients from several days to just half an hour. Read more...


Single Protein Causes Parkinson's Disease, Multiple Systems Atrophy

June 11, 2015 8:37 am | by KU Leuven | News | Comments

Typical of neurodegenerative disorders is the disrupted communication between brain cells together with a loss of cells in specific brain regions. Read more...


South Korea Reports 10th Death from MERS Virus

June 11, 2015 8:31 am | by The Associated Press | News | Comments

South Korea reported a 10th death from the MERS virus on Thursday, although officials say they believe the disease has peaked. Read more...


Nanotechnology: The Big Challenge Behind the Characterization of the Small

June 10, 2015 2:35 pm | by Ellie Gadd, Science Writer, LGC | Articles | Comments

Nanotechnologies are everywhere, from the medicines we take to the food we eat, but what do we really know about the potential effects when they come into contact with complex matrices and how do we ensure that nanoproducts are safe? The global market for nanomaterials is estimated by the European Commission to be...


Lilly Announces Positive Phase 3 Results for Psoriasis Drug

June 10, 2015 1:36 pm | News | Comments

Eli Lilly and Company announced today that detailed results of two pivotal Phase 3 studies for ixekizumab were published by The Lancet. The UNCOVER-2 and UNCOVER-3 clinical studies of more than 2,500 patients found ixekizumab to be statistically superior to etanercept and placebo on all measures of skin clearance. Read more...


Clinicians Reluctant to Prescribe Medication That Counteracts Opioid Overdose

June 10, 2015 1:11 pm | News | Comments

A variety of factors, including questions about risk and reluctance to offend patients, limits clinician willingness to prescribe a potentially life-saving medication that counteracts the effects of an opioid overdose, according to a Kaiser Permanente Colorado study published today in the Journal of General Internal Medicine. Read more...

California Lawmakers Pass Vaccine Bill Amid Emotional Debate

June 10, 2015 1:06 pm | by Julia Horowitz, Associated Press | News | Comments

California lawmakers on Tuesday approved a hotly contested bill that would impose one of the strictest vaccination laws in the country, after five hours of highly emotional testimony that brought hundreds of opponents to the Capitol. Read more...


Mylan Expands Voluntary Recall of Select Injectable Products

June 10, 2015 12:16 pm | by Ryan Bushey, Associate Editor | Articles | Comments

This medication could cause severe health problems if administered when infected with an unknown pollutant. Read more...


Z-Pak Can Kill ‘Superbugs,’ Says New Study

June 10, 2015 12:09 pm | by Seth Augenstein, Digital Reporter | News | Comments

Antibiotic resistance is sweeping the globe, with so-called “superbugs” sickening 2 million people and killing 20,000 in the U.S. alone each year. But a key weapon might have been under everyone’s nose for years, according to a new study, which may prove to be controversial. Read more...


FDA Panel Recommends Approval of New Cholesterol-Lowering Drug

June 10, 2015 11:25 am | by Stephanie Guzowski, Editor | News | Comments

A Food and Drug Administration (FDA) advisory panel on Tuesday recommended approval of a new injectable drug, alirocumab (Praluent) from Sanofi SA and Regeneron Pharmaceuticals, to help prevent heart attacks by lowering cholesterol. The new drug may be more powerful and carry fewer side effects than statins. Read more...


Expert Argues Against Smokescreen on E-cigarette Research

June 10, 2015 8:37 am | by University of Queensland | News | Comments

A leading Australian substance abuse expert is pleading for moderation in policies on e-cigarettes. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.